For years, Americans were told their only hope was to roll up their sleeves for Pfizer, Moderna, and the rest of the vaccine cartel.
Trillions of dollars flowed into their coffers while dissenting doctors were silenced, families were divided, and countless workers lost their jobs under vaccine mandates.
However, a peer-reviewed study out of Germany now shows that a cheap, decades-old nasal spray, azelastine, may do what the so-called ‘miracle’ experimental COVID jabs never accomplished: stop infection.
According to new findings published in JAMA Internal Medicine this week, all it may have taken to block infections was a $10 bottle of over-the-counter nasal spray used for seasonal allergies.
Researchers at Saarland University Hospital in Germany ran a phase 2 double-blind, placebo-controlled clinical trial on 450 healthy adults between March 2023 and July 2024.
Participants were randomly divided into two groups:
- 227 volunteers received azelastine nasal spray (a common antihistamine used for allergies) three times a day.
- 223 volunteers got a placebo spray.
All participants were tested for COVID twice per week for nearly two months.